News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
234 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase II Trial for Alzheimer’s Disease
This will be the third milestone payment under the 2012 strategic collaboration and licensing agreement with Genentech for anti-Tau antibodies for the treatment of AD and other neurodegenerative diseases.
November 2, 2017
·
8 min read
Business
Loxo Oncology Announces Third Quarter 2017 Financial Results
The company reported financial results for the third quarter ended September 30, 2017.
November 2, 2017
·
13 min read
Business
INSYS Therapeutics Reports Third Quarter 2017 Results
Gross revenue was $48.9 million, resulting in net revenue of $30.7 million.
November 2, 2017
·
13 min read
INTEGRA Highlights Benefits of Low Retention Pipette Tips
The recently published Performance of Low Retention GripTips from INTEGRA demonstrates how these high quality consumables can improve pipetting performance for viscous and low surface tension liquids.
November 2, 2017
·
1 min read
Business
Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements
The company reported financial results for the third quarter ended September 30, 2017 and provided an overview of recent achievements.
November 2, 2017
·
8 min read
Business
iPharma Enters Into Licensing Agreement With Boehringer Ingelheim to Obtain Worldwide Rights to FAK Inhibitor Oncology Development Program
iPharma, Ltd. announced today that it has entered into an exclusive worldwide license agreement with Boehringer Ingelheim.
November 2, 2017
·
3 min read
Pharm Country
AIT Therapeutics Completes Treatment of Patient Infected With NTM abscessus at the NIH With its Nitric Oxide Treatment
The patient, who has cystic fibrosis, was diagnosed with M. abscessus more than 5 years ago.
November 2, 2017
·
4 min read
Business
UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors
Most recently, Ms. Butitta served as COO of Kite, where she played an instrumental role leading up to Kite’s acquisition by Gilead.
November 2, 2017
·
4 min read
Enzymotec Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters
The record date for shareholders entitled to vote at the Meeting is Monday, November 13, 2017.
November 2, 2017
·
9 min read
Business
Cytori to Webcast Third Quarter Financial Results on November 9 - Nov. 2, 2017
The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.
November 2, 2017
·
1 min read
Previous
12 of 24
Next